These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9369430)

  • 41. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL; Pelus LM; Lord KA
    Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
    Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
    Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative.
    Chamorro ME; Wenker SD; Vota DM; Vittori DC; Nesse AB
    Biochim Biophys Acta; 2013 Aug; 1833(8):1960-8. PubMed ID: 23602701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of erythropoietic colonies in a human chronic myelogenous leukemia cell line.
    Hoffman R; Murnane MJ; Benz EJ; Prohaska R; Floyd V; Dainiak N; Forget BG; Furthmayr H
    Blood; 1979 Nov; 54(5):1182-7. PubMed ID: 291442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research.
    Skopek R; Palusińska M; Kaczor-Keller K; Pingwara R; Papierniak-Wyglądała A; Schenk T; Lewicki S; Zelent A; Szymański Ł
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
    Takeda J; Yoshida K; Nakagawa MM; Nannya Y; Yoda A; Saiki R; Ochi Y; Zhao L; Okuda R; Qi X; Mori T; Kon A; Chiba K; Tanaka H; Shiraishi Y; Kuo MC; Kerr CM; Nagata Y; Morishita D; Hiramoto N; Hangaishi A; Nakazawa H; Ishiyama K; Miyano S; Chiba S; Miyazaki Y; Kitano T; Usuki K; Sezaki N; Tsurumi H; Miyawaki S; Maciejewski JP; Ishikawa T; Ohyashiki K; Ganser A; Heuser M; Thol F; Shih LY; Takaori-Kondo A; Makishima H; Ogawa S
    Blood Cancer Discov; 2022 Sep; 3(5):410-427. PubMed ID: 35839275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and Pathological Significance of Autoantibodies to Erythropoietin Receptor in Type 2 Diabetic Patients With CKD.
    Hara A; Furuichi K; Koshino A; Yasuda H; Tran TTT; Iwata Y; Sakai N; Shimizu M; Kaneko S; Nakamura H; Wada T
    Kidney Int Rep; 2018 Jan; 3(1):133-141. PubMed ID: 29340323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus.
    Hashimoto K; Harada M; Kamijo Y
    Int J Hematol; 2016 Oct; 104(4):502-5. PubMed ID: 27338269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.
    Aizawa K; Kawasaki R; Tashiro Y; Hirata M; Endo K; Shimonaka Y
    Int J Hematol; 2016 Aug; 104(2):182-9. PubMed ID: 27084258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biosimilars entering the clinic without animal studies. A paradigm shift in the European Union.
    van Aerts LA; De Smet K; Reichmann G; van der Laan JW; Schneider CK
    MAbs; 2014; 6(5):1155-62. PubMed ID: 25517301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone.
    Aoki K; Ono Y; Tabata S; Matsushita A; Ishikawa T
    Int J Hematol; 2013 Feb; 97(2):272-4. PubMed ID: 23355260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor.
    Ghaffari S; Jagani Z; Kitidis C; Lodish HF; Khosravi-Far R
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6523-8. PubMed ID: 12750477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor.
    Klingmüller U
    Eur J Biochem; 1997 Nov; 249(3):637-47. PubMed ID: 9395308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukins and colony stimulating factors in human myeloid leukemia cell lines.
    Hassan HT; Drexler HG
    Leuk Lymphoma; 1995 Dec; 20(1-2):1-15. PubMed ID: 8750618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment and characterization of a new erythropoietin-dependent acute myeloid leukemia cell line, AS-E2.
    Miyazaki Y; Kuriyama K; Higuchi M; Tsushima H; Sohda H; Imai N; Saito M; Kondo T; Tomonaga M
    Leukemia; 1997 Nov; 11(11):1941-9. PubMed ID: 9369430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
    Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
    Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.